Literature DB >> 34270709

Minimal invasive temporary percutaneous right ventricular circulatory support after left ventricular assist device implantation.

Ruslan Natanov1, Marcel Ricklefs2, Nodir Madrahimov1, Felix Fleissner, Axel Haverich1, Christian Kühn1.   

Abstract

OBJECTIVES: Cardiogenic shock is a life-threatening situation with high mortality rates. Mechanical unloading of the left ventricle may be achieved via left ventricular assist device (LVAD) implantation. Postoperative right ventricular (RV) failure, however, has very limited therapeutic options and is associated with increased postoperative mortality. In this paper, we describe a percutaneous right heart bypass for temporary postoperative RV support.
METHODS: We retrospectively examined all patients receiving percutaneous RV mechanical support after LVAD implantation. All patients receiving trans-jugular mechanical right heart bypass during or after LVAD implantation in our tertiary medical centre between November 2014 and December 2019 were examined retrospectively. The venous draining cannula was placed in the femoral vein; the pulmonary cannula was placed in the pulmonary artery using fluoroscopy.
RESULTS: In total, 14 patients received RV support using the trans-jugular technique. Mean age was 48.4 ± 14.9 years. Nine patients were treated with mechanical circulatory support before LVAD implantation. Biventricular support was done in 7 patients. All patients were treated with an Heartware HVAD . Mean postoperative intensive care unit stay was 46.3 ± 32.4 days. Mean right heart bypass support time was 10.6 ± 4.3 days. Twelve patients (86%) could be bridged to RV recovery, RV assist device implantation or heart transplantation.
CONCLUSIONS: Percutaneous RV mechanical support is feasible, safe and shows acceptable outcome. Early implantation of RV support may contribute to successful outcome after LVAD implantation.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Extracorporeal membrane oxygenation; Left ventricle assist device; Right heart bypass; Right ventricular failure

Mesh:

Year:  2021        PMID: 34270709      PMCID: PMC8759478          DOI: 10.1093/icvts/ivab167

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  23 in total

1.  Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.

Authors:  Pierre-Emmanuel Noly; Matthias Kirsch; Astrid Quessard; Philippe Leger; Alain Pavie; Julien Amour; Pascal Leprince
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-03-21

Review 2.  Cannulation techniques for extracorporeal life support.

Authors:  Evgeny Pavlushkov; Marius Berman; Kamen Valchanov
Journal:  Ann Transl Med       Date:  2017-02

Review 3.  Right Ventricular Strain to Assess Early Right Heart Failure in the Left Ventricular Assist Device Candidate.

Authors:  Fatih Gumus; Cahit Sarıcaoglu; Mustafa Bahadir Inan; Ahmet Ruchan Akar
Journal:  Curr Heart Fail Rep       Date:  2019-12

4.  Temporary percutaneous right ventricular support using a centrifugal pump in patients with postoperative acute refractory right ventricular failure after left ventricular assist device implantation.

Authors:  Assad Haneya; Alois Philipp; Thomas Puehler; Leopold Rupprecht; Reinhard Kobuch; Michael Hilker; Christof Schmid; Stephan W Hirt
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

5.  Frequency and Consequences of Right-Sided Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation.

Authors:  Chitaru Kurihara; Andre C Critsinelis; Masashi Kawabori; Tadahisa Sugiura; Gabriel Loor; Andrew B Civitello; Jeffrey A Morgan
Journal:  Am J Cardiol       Date:  2017-10-31       Impact factor: 2.778

6.  Clinical management of continuous-flow left ventricular assist devices in advanced heart failure.

Authors:  Mark S Slaughter; Francis D Pagani; Joseph G Rogers; Leslie W Miller; Benjamin Sun; Stuart D Russell; Randall C Starling; Leway Chen; Andrew J Boyle; Suzanne Chillcott; Robert M Adamson; Margaret S Blood; Margarita T Camacho; Katherine A Idrissi; Michael Petty; Michael Sobieski; Susan Wright; Timothy J Myers; David J Farrar
Journal:  J Heart Lung Transplant       Date:  2010-02-24       Impact factor: 10.247

Review 7.  Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.

Authors:  Sean van Diepen; Jason N Katz; Nancy M Albert; Timothy D Henry; Alice K Jacobs; Navin K Kapur; Ahmet Kilic; Venu Menon; E Magnus Ohman; Nancy K Sweitzer; Holger Thiele; Jeffrey B Washam; Mauricio G Cohen
Journal:  Circulation       Date:  2017-09-18       Impact factor: 29.690

8.  Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective.

Authors:  Robert J Goldberg; Frederick A Spencer; Joel M Gore; Darleen Lessard; Jorge Yarzebski
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

9.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

10.  Pulmonary artery cannulation to enhance extracorporeal membrane oxygenation management in acute cardiac failure.

Authors:  Roberto Lorusso; Giuseppe Maria Raffa; Samuel Heuts; Valeria Lo Coco; Paolo Meani; Ehsan Natour; Elham Bidar; Thijs Delnoij; Antonio Loforte
Journal:  Interact Cardiovasc Thorac Surg       Date:  2020-02-01
View more
  1 in total

1.  Gently handling the acutely failing right ventricle … at last!

Authors:  Roberto Lorusso; Silvia Mariani; Justine M Ravaux
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.